Literature DB >> 12101424

MLL5, a homolog of Drosophila trithorax located within a segment of chromosome band 7q22 implicated in myeloid leukemia.

Brooke M Emerling1, Jeannette Bonifas, Christian P Kratz, Shane Donovan, Brigit R Taylor, Eric D Green, Michelle M Le Beau, Kevin M Shannon.   

Abstract

Proteins encoded by Polycomb and Trithorax-group (Pc-G and Trx-G) genes regulate developmental fates by maintaining or repressing HOX gene expression, respectively. In a search for candidate myeloid leukemia tumor suppressor genes from a approximately 2.5 Mb commonly-deleted segment within chromosome band 7q22, we identified a novel human Trithorax (Trx) family member named MLL5. Trx-G genes encode proteins that modulate transcriptional programs through protein-protein interactions that are mediated by PHD and SET domains, and by binding to DNA via A-T hooks and methyltransferase homology motifs. MLL5 is a homolog of the Drosophila gene CG9007; it encodes a 6.5 kb mRNA that is expressed widely. MLL5 includes a SET domain and a single PHD finger, but lacks A-T hooks and methyltransferase homology domains that are found in MLL. The leukemia cell line RCV-ACV-A carries a heterozygous missense mutation within the PHD domain; however, no mutations within the MLL5 coding region were detected in primary leukemias. MLL5 is a novel mammalian Trx-G gene that might modulate transcription by protein association.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12101424     DOI: 10.1038/sj.onc.1205615

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  46 in total

1.  Binding to nonmethylated CpG DNA is essential for target recognition, transactivation, and myeloid transformation by an MLL oncoprotein.

Authors:  Paul M Ayton; Everett H Chen; Michael L Cleary
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

Review 2.  Trithorax group proteins: switching genes on and keeping them active.

Authors:  Bernd Schuettengruber; Anne-Marie Martinez; Nicola Iovino; Giacomo Cavalli
Journal:  Nat Rev Mol Cell Biol       Date:  2011-11-23       Impact factor: 94.444

3.  Knockdown of ALR (MLL2) reveals ALR target genes and leads to alterations in cell adhesion and growth.

Authors:  Irina Issaeva; Yulia Zonis; Tanya Rozovskaia; Kira Orlovsky; Carlo M Croce; Tatsuya Nakamura; Alex Mazo; Lea Eisenbach; Eli Canaani
Journal:  Mol Cell Biol       Date:  2006-12-18       Impact factor: 4.272

4.  A gene-trap strategy identifies quiescence-induced genes in synchronized myoblasts.

Authors:  Ramkumar Sambasivan; Grace K Pavlath; Jyotsna Dhawan
Journal:  J Biosci       Date:  2008-03       Impact factor: 1.826

Review 5.  MLL5 (KMT2E): structure, function, and clinical relevance.

Authors:  Xiaoming Zhang; Wisna Novera; Yan Zhang; Lih-Wen Deng
Journal:  Cell Mol Life Sci       Date:  2017-02-10       Impact factor: 9.261

6.  UpSET-ting the balance: modulating open chromatin features in metazoan genomes.

Authors:  Hector Rincon-Arano; Susan M Parkhurst; Mark Groudine
Journal:  Fly (Austin)       Date:  2013-05-06       Impact factor: 2.160

7.  Phosphorylation of mixed lineage leukemia 5 by CDC2 affects its cellular distribution and is required for mitotic entry.

Authors:  Jie Liu; Xiao Ning Wang; Fei Cheng; Yih-Cherng Liou; Lih-Wen Deng
Journal:  J Biol Chem       Date:  2010-05-03       Impact factor: 5.157

Review 8.  Molecular pathogenesis of MLL-associated leukemias.

Authors:  Mariko Eguchi; Minenori Eguchi-Ishimae; Mel Greaves
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

9.  Structural Insight into Recognition of Methylated Histone H3K4 by Set3.

Authors:  Jovylyn Gatchalian; Muzaffar Ali; Forest H Andrews; Yi Zhang; Alexander S Barrett; Tatiana G Kutateladze
Journal:  J Mol Biol       Date:  2016-09-30       Impact factor: 5.469

10.  MLL5 contributes to hematopoietic stem cell fitness and homeostasis.

Authors:  Yan Zhang; Jasmine Wong; Mark Klinger; Mary T Tran; Kevin M Shannon; Nigel Killeen
Journal:  Blood       Date:  2008-09-25       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.